- 输血相容性检测及疑难病例分析
- 桂嵘 张志昇 王勇军
- 1781字
- 2020-08-29 08:11:16
参考文献
1.何维.医学免疫学.第2版.北京:人民卫生出版社,2010
2.李勇,马学严.实用血液免疫学血型理论和实验技术.北京:科学出版社,2006
3.魏亚明,吕毅.基础输血学.北京:人民卫生出版社,2011
4.王培华.输血技术学.第2版.北京:人民卫生出版社,2002
5.Mark K. Fung,Anne F. Eder,Steven L. Spitalnik,et al. Technical Manual,19th ed. AABB. 2017
6.Mark K. Fung,Brenda J. Grossman,Christopher D. Hillyer,et al. Technical Manua,18th ed. AABB. 2014
7.杰夫·丹尼尔著.人类血型.朱自严译.北京:科学出版社,2007
8.Daniels G. Human blood groups. 3rd ed. Oxford:Blackwell Sience,2013
9.兰炯采,贠中桥,陈静娴.输血免疫实验学技术.北京:人民卫生出版社,2011
10.Liesveld JL,Rothberg PG. Mixed chimerism in SCT:conflict or peaceful coexistence? Bone Marrow Transplant,2008,42(5):297-310
11.Rowley SD,Liang PS,Ulz L. Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components. Bone Marrow Transplant,2000,26(7):749-757
12.Bianco T,Farmer BJ,Sage RE,et al. Loss of red cell A,B,and H antigens is frequent in myeloid malignancies.Blood,2001,97(11):3633-3639
13.安万新,于卫建.输血技术学.第2版.北京:科学技术文献出版社,2009
14.刘景汉,汪德清.临床输血学.北京:人民卫生出版社,2011
15.Chang CS,Lin KT,Chang JG,et al. Molecular basis of the A2B in Taiwan. Int J Hematol,2008,88(2):127-133
16.Hua Z,Li L,Li Z. Serological characteristic and molecular basis of A2 subgroup in Shanghai population.Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2014,31(5):659-662
17.Ying Y,Hong X,Xu X,et al. Serological characteristic and molecular basis of A2 subgroup in the Chinese population. Transfus Apher Sci,2013,48(1):67-74
18.Pipatvanichkul A,Permpikul P,Vejbaesya S,et al. Mutation of ABO gene in Thai blood donors with A3 phenotype. J Med Assoc Thai. 2011,94(3):379-385
19.VOS GH. Five Examples of Red Cells with the Ax subgroup of blood group. Vox Sang,1964,9(2):160-167
20.Lin-Chu M,Broadberry RE,Chiou PW. The B3 phenotype in Chinese. Transfusion,1986,26(5):428-430
21.Rajeswari. Subramaniyan Diminished expression of B antigen mimicking B3 phenotype in a patient with AML-M3:a rare case report. Rev Bras Hematol Hemoter,2016,38(3):264-266
22.Pham BN,Roussel M,Gien D,et al. Molecular analysis of patients with weak D and serologic analysis of those with anti-D (excluding type 1 and type 2). Immunohematology,2013,29(2):55-62
23.Geoff Daniels. Variants of RhD-current testing and clinical consequences. Br J Haematol,2013,161(4):464-470
24.JiYL,Van der Schoot CE. Red blood cell genotyping in China. ISBT Science,2016,11(S2):55-68
25.Li Q,Hou L,Guo ZH,et al. Molecular basis of the RHD gene in blood donors with DEL phenotypes in Shanghai.Vox Sang,2009,97(2):139-146
26.Körmöczi GF,Gassner C,Shao CP,et al.A comprehensive analysis of DEL types:partial DEL individuals are prone to anti-D alloimmunization. Transfusion,2005,45(10):1561-1567
27.Kim KH,Kim KE,Woo KS,et al. Primary anti-D immunization by DEL red blood cells. Korean J Lab Med,2009,29 (4):363-365
28.Luettringhaus TA,Cho D,Ryang DW,et al. An easy RHD genotyping strategy for D-East Asian persons applied to Korean blood donors. Transfusion,2006,46(12):2128-2137
29.Shao CP. Transfusion of RhD-positive blood in “Asia type” DEL recipients. N Engl J Med.,2010,362(5):472-473
30.Sakuma K,Kubo N,Nishimura K,et al. Anti-D antibody production due to transfusion of Del type RBCs to a D-negative recipient:a case report. Japanese Journal of Transfusion and Cell Therapy,2010,56(3):383-385
31.Yasuda H,Ohto H,Sakuma S,et al. Secondary anti-D immunization by Del red blood cells. Transfusion,2005,45(10):1581-1584
32.Yoon J,Koh YE,Kim HN,et al. A Case of Primary Anti-D Alloimmunization by RHD (c.1227G>A)DEL Red Blood Cell Transfusion. Korean J Blood Transfus,2016,27(2):169-173
33.Songsak Srijinda,Chamaiporn Suwanasophon,Unchalee Visawapoka,et al. RhC Phenotyping,Adsorption/Elution Test,and SSP-PCR:The Combined Test for D-Elute Phenotype Screening in Thai RhD-Negative Blood Donors. ISRN Hematology,2012,2012(1):358-316
34.Chen JC,Lin TM,Chen YL,et al. RHD 1227A is an important genetic marker for RhD(el)individuals. Am J Clin Pathol.,2004,122(2):193-198
35.Wang YH,Chen JC,Lin KT,et al. Detection of RhD(el)in RhD-negative persons in clinical laboratory. J Lab Clin Med.,2005,146(6):323-325
36.Tian L,Song N,Yao ZQ,et al. A family study of the Chinese Rhnull individual of the regulator type:a novel single missense mutation identified in RHAG gene. Transfusion,2011,51(12):2686-2689
37.Hou L,Yan QD,Tian L. A novel nonsense mutation in RHAG gene responsible for Rhnull phenotype in a Chinese individual. Transfus Apher Sci,2017,56(2):220
38.Yan F,Lin YS,Xu ZY,et al. Which RhD alleles are risk factors stimulating allo- anti-D? APJBG,2017,3:29-32
39.庄光艳,张烨,王颖,等.Rh血型系统ce复合抗原抗体抗-ce的研究.北京医学,2016,38(10):1070-1072
40.O’Reilly RA,Lombard CM,Azzi RL. Delayed hemolytic transfusion reaction associated with Rh antibody anti-f:first reported case. Vox Sang,1985,49(5):336-339
41.Spielmann W,Seidl S,Von Pawel J. Anti-ce (anti-f)in a CDe/cD- Mother,as a Cause of Haemolytic Disease of the Newborn. Vox Sang,1974,27(5):473-477
42.Gong Y,Ai Y,Zhou R. Rare case of hemolytic death of the newborn due to anti-hr0 and anti-e. J Obstet Gynaecol Res,2011,37(5):465-467
43.Yu SH,Xiao J,Xu H,et al. The best strategy of blood transfusion in patients with Rhnull syndrome. APJBG,2017,2:71-74
44.Daniels G. Human blood groups. 3rd ed. Oxford:Blackwell Sience,2013
45.Dwyre DM,Clapper A,Heintz M,et al. A red blood cell autoantibody with mimicking anti-E specificity.Transfusion,2004,44(9):1287-1292
46.王全立,罗卫东,穆世杰.临床输血与免疫.西安:第四军医大学出版社,2007
47.Höglund P,Rosengren-Lindquist R,Wikman AT.A severe haemolytic transfusion reaction caused by anti-Lea active at 37℃. Blood Transfus,2013,11(3):456-459
48.Lo SC,Chang JS,Lin SW,et al. Immunological characterization of anti-Mia,a red blood cell alloantibody,in Taiwan. Vox Sang,2002,83(1);162-164
49.Chu CC,Ho HT,Lee HL,et al. Anti-“Mia” immunization is associated with HLA-DRB1*0901.Transfusion,2009,49(2):189-192
50.Wu KH,Chang JG,Lin M,et al. Hydrops foetalis caused by anti-Mur in first pregnancy-a case report. Transfus Med,2002,12(1):325-327
51.刘达庄,朱自严,Byrne P,等.低频率抗体抗-Mur引起的溶血性输血反应.中国输血杂志,2000,13(1):8-10
52.高峰.输血与输血技术.北京:人民卫生出版社,2003
53.王学锋,滕本秀,欧阳锡林.临床输血1000问.北京:人民卫生出版社,2011
54.胡丽华.临床输血学检验技术.北京:人民卫生出版社,2015
55.Johnson ST.JMH blood group system. Immunohematology,2014,30(1):18-23
56.Bellver-Pradas J,Arriaga-Chafer F,Perales-Mar í n A,et al.Obstetric significance of anti-Jr(a)antibody. Am J Obstet Gynecol,2001,184(2):75-76
57.Castilho L,Reid ME. A review of the JR bloodgroupsystem. Immuno- hematology,2013,29(2):63-68